• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

RPM company Cadence scores $100M, boosting valuation to $1B

Share:

December 18, 2021

Remote monitoring and virtual care platform Cadence raised $100 million in a Series B financing round led by Coatue Management, bringing its valuation to more than $1 billion.

Existing investors including General Catalyst and Thrive Capital also participated.

The funding comes months after the company emerged from stealth with $41 million and a partnership with health system LifePoint Health to install the system at its facilities.

WHAT IT DOES

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Cadence offers a remote patient monitoring platform for managing chronic conditions, like COPD, hypertension, heart failure and Type 2 diabetes. Patients have connected devices that track their vitals, including heart rate, blood pressure, blood glucose and weight.

Providers use this data to make changes to their patients’ care plans if necessary. Clinicians and patients can also call or text one another if there’s a concerning result, and engage in telehealth appointments as needed.

Since the company’s launch in August, it has been working with health systems to help patients in rural areas with guideline directed medical therapy for heart failure.

“Cadence is building an innovative digital healthcare infrastructure with the most forward-thinking, patient-centric health systems in the country,” CEO and founder Chris Altchek said in a statement.

“Our partners will define a new standard for the delivery of healthcare at home over the next decade, reducing disparities in care, especially among those who have been unable to easily access quality healthcare.”

MARKET SNAPSHOT

Remote patient monitoring and virtual care are fast-growing trends in the health technology space. Managing chronic conditions is of particular concern, as the CDC estimates six in ten adults in the U.S. have at least one chronic disease.

Sound Life Sciences, a University of Washington spinout, recently scored FDA 510(k) clearance for its prescription app that allows a smartphone or smart speaker to remotely monitor changes in breathing, which can then be reported back to the user or a clinician.

Amazon recently launched its Alexa Together subscription service, pitched as a way for family members to use the Alexa voice assistant to monitor older family members in their homes. It also partnered with third-party services to integrate fall-detection technology into the service.

Other players include Current Health, which was snapped up by retail giant Best Buy; Biobeat, which launched a “hospital at home” version of its product early this year; and OnSky Health, which released its continuously contact-free vital-sign-sensing system in October.

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Sonendo® Announces GentleWave® System Integration With TDO® Endodontic SoftwareSonendo® Announces GentleWave® System Integration With TDO® Endodontic Software
  • DelMar Announces Approval of Merger by StockholdersDelMar Announces Approval of Merger by Stockholders
  • Exclusive Demand for Diabetic Neuropathic Pain Drug Market Projected to Witness Vigorous Expansion by 2020-2027 by Major innovators like Astellas Pharma, AstraZeneca PlcExclusive Demand for Diabetic Neuropathic Pain Drug Market Projected to Witness Vigorous Expansion by 2020-2027 by Major innovators like Astellas Pharma, AstraZeneca Plc
  • A Matter of Trust: 3 Tips for Outsourcing Out-of-Pocket SupportA Matter of Trust: 3 Tips for Outsourcing Out-of-Pocket Support
  • GSK completes acquisition of TESARO, an oncology focused biopharmaceutical companyGSK completes acquisition of TESARO, an oncology focused biopharmaceutical company
  • Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic SolutionsRepligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions
  • Fresenius Health Partners, InterWell Health, and Cricket Health Announce $2.4B MergerFresenius Health Partners, InterWell Health, and Cricket Health Announce $2.4B Merger
  • TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And FinancingTapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications